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Introduction 
The term aneurysm describes a localised widening or ballooning of a section of in a artery, an 
increase of greater than 50% of normal size is defined as aneurysmal, (Upchurch & Criado, 2009).  
Aneurysmal changes can be found in any artery but are most commonly seen in the aorta, (Nienaber 
& Fattori, 2012).  Aneurysms can be asymptomatic or symptomatic but may be life threatening if 
there is sudden dissection or rupturing.   This article describes the differences between abdominal 
and thoracic aneurysms and explores the incidence, causes and treatment of thoracic aneurysmal 
disease, highlighting the importance of vigilant post-operative care. 
Definition of aortic aneurysm and Incidence 
Aneursyms are classified by location; 80% of all aneurysms are Abdominal Aortic Aneurysms (AAA) 
with 10% categorised as Thoracic Aorta Aneurysms (TAA), (Nienaber & Fattori, 2012; Fournier & 
Zanoff, 2012).  The aorta is anatomically divided into two sections: the thoracic aorta which runs 
from the heart to the diaphragm and the abdominal aorta which continues from the diaphragm to 
the aortic bifurcation. The thoracic aorta is further divided into 3 sections: the ascending aorta 
(which contains the aortic root, sinuses of valsalva & a tubular segment); the aortic arch and the 
descending aorta, (Topol, 2007). Approximately 60% of all thoracic aneurysms involve the aortic root 
or the ascending thoracic aorta, 10% involve the arch, 40% involve the descending aorta, and the 
remaining 10% involves both the thoracic and abdominal aorta (thoraco-abdominal), (Isselbacher, 
2004).  
Thoracic Aneurysm Symptomology 
The majority of aneurysms are asymptomatic on diagnosis, having been found incidentally on 
imaging procedures for other health concerns. In the case of thoracic aneurysms if they do cause 
symptoms for the patient this is normally related to the direct compression of other intrathoracic 
structures.  Such compression can cause breathing difficulties due to tracheal deviation, difficulty 
swallowing due to compression of the oesophagus, or hoarseness of voice due to compression of the 
laryngeal nerve, (Stoetling et al, 2012). Occasionally patients who have an aneurysm of the 
ascending aorta complain of deep, aching chest pain and/or back pain which can radiate to the neck 
and jaw. In the case of descending aortic aneurysms the pain is more commonly found in the back, 
between the shoulder blades. Those who have symptomatic thoraco-abdominal aneurysms may 
complain of lower back pain. Rapidly expanding thoracic aneurysms can cause severe chest pain and 
should be viewed as a precursor to rupture, (Nienaber & Fattori, 2012).  
Rupture can at times be the first indication of the presence of an aneurysm, resulting in massive 
haemorrhage into the mediastinum, the pleural space, which can affect the oesphophagus and the 
bronchial tree. If the site of rupture is in the ascending aorta this may result in a haemopericardium 
and cardiac tamponade.  A rarer symptom is that of haemoptysis, which can indicate a rupture of 
the descending thoracic aorta, the haemoptysis is the result of the aorta become adhered to one of 
the lungs, (Nienaber & Fattori, 2012).  
In addition to aneurysms the aorta can also suffer from dissection, although uncommon, aortic 
dissection begins with tear in the inner layer of the aortic wall normally within the thoracic aorta. 
Dissection occurs when the innermost layer of the aortic wall (the intima) weakens. This results in a 
tear or intimal flap, which allows blood to be channeled into the wall of the aorta.  The pressure of 
the blood separates the arterial layers leading to the development of a false lumen.  Aortic 
dissection is often described using the DeBakey classification (fig 1), which clearly defines the 
severity of the dissection and its location. Patients suffering acute dissection often complain of acute 
chest or back pain and in some cases cardiac tamponade can occur, (Baliga et al, 2007).  The cause of 
aortic dissection is unclear and remains under investigation.  However, there are several risk factors 
associated with aortic dissection: these include hypertension, connective tissue disorders, 
atherosclerosis, cystic medial disease, aortitis and trauma, (Foster & Turley, 2016). 
 
Causes 
The mechanisms for initiating and stimulating the progression of aneurysms remains poorly 
understood, (Golledge & Norman, 2010).  Different factors are thought to drive aortic dilation and 
rupture at different aortic sites, (Norman and Powel 2010).  The exact cause of most aortic 
aneurysms is unknown, (Sakalihasan et al., 2005). However, in some specific cases the cause of the 
aneurysm can be identified. These include: trauma; acute infection (brucellosis, salmonellosis); 
chronic infection (tuberculosis); inflammatory diseases (Behçet and Takayasu disease) and 
connective tissue disorders, (Sakalihasan et al., 2005).  There are several syndromic and non-
syndromic genetic conditions that are associated with the development of thoracic aortic aneurysms 
including Marfan’s syndrome, Loeys-Dietz syndrome, Turner syndrome, bicuspid aortic valve, and 
other genetic mutations, (Hiratzka et al 2010).  
Risk Factors 
Using medical profiles of patients undergoing treatment for aortic dissection, ruptured aneurysms 
and electively treated aneurysms has allowed the identification of specific factors which increase the 
risk of developing aneurysmal disease. These include:  
Smoking: This is a risk factor across the entire range of aortic diseases, although with different risk 
magnitudes for different diseases, (Landenhead et al 2015). The abdominal aorta appears to be 
particularly susceptible to smoking, (Jovin et al 2012). The prevalence of AAA’s in tobacco smokers is 
more than four times that of life-long non-smokers, (Sakalihasan et al., 2005). Smoking is also a risk 
factor for aortic dissection and thoracic aortic aneurysm, (Landenhead et al 2015). Smoking is the 
main modifiable risk factor that has been associated with the development, expansion and rupture 
of AAA, (Brady et al., 2004). However no such association has been proven for thoracic aortic 
aneurysm, (Sidoff et al 2014). 
Hypertension: In a study by Landenhead et al., (2015) hypertension was present in 86% of 
individuals who subsequently developed aortic dissection. Howard et al., (2013) suggest that half of 
aortic dissection events could be prevented by pharmacological intervention in hypertensive 
subjects.  Studies have also demonstrated significant association between AAA and hypertension, 
(Kent et al., 2010). However, hypertension is not significantly associated with thoracic aortic 
aneurysms, (Landenhead et al., 2015). 
Age and sex: Increasing age and the male sex have been shown to increase the risks of AAA, TAA and 
aortic dissection, (Forsdahl et al., 2009; Landenhead et al., 2015). In men the incidence of AAA is 
approximately 25 per 100,000 at age 50, increasing to 78 per 100,000 in those older than 70 years, 
(Hay et al., 2009).  This is compared to a much lower prevalence in women, 13 per 100,000 aged 
over 65, (Scott et al., 2002). 
Atherosclerosis: Atherosclerosis is associated with all types of aneurysmal disease, with a large 
proportion of patients having a history of coronary disease or peripheral arterial disease.  However, 
whether there is any association in terms of causation of the aneurysms is still under debate, 
(Norman and Powel 2010). This link may be simply due to having similar risk factors for the 
development of both conditions.  Furthermore, aneurysms rarely form in locations that are 
particularly prone to atherosclerosis (e.g., superficial femoral artery), (Norman and Powell, 2010) 
which suggests association rather than causative, (Kent et al., 2010 ). Interestingly diabetes does 
appear to offer some protection against the formation of AAA, (De Rango et al., 2014) and thoracic 
aneurysms, (Landenhead et al 2015).   
Imaging 
Preferred diagnostic modalities are Computerized Tomography (CT) or Magnetic Resonance Imaging 
(MRI).  Contrast-enhanced CT or CT angiography can be used to ascertain the extent of aneurysmal 
dilatation, (Ramanath et al. 2009).  It is recommended that patients in whom thoracic aneurysms are 
suspected undergo CT imaging of the entire aorta, as up to 20% of patients with thoracic aortic 
aneurysms also have distal involvement, (Booher et al., 2011). 
 
Treatment options/decision making 
 
Treatment options for thoracic aortic aneurysm are open surgical repair, endovascular stent grafting 
or conservative management, (Sastry et al., 2015).  In order to make decisions regarding the 
treatment of thoracic aortic aneurysms, the location, size and shape of the aneurysm must be 
established.  The risk of rupture largely (but not exclusively) depends on aneurysm size, though a 
range of factors influence the risks of intervention.  All patents with aortic aneurysms are discussed 
within a Multi-Disciplinary Team (MDT) meeting, these meetings include inputs from vascular 
interventional radiologists, vascular consultants, anaesthetist consultants and specialist nurses.   The 
MDT plays a key role in reviewing the risks and benefits of intervention on an individual patient basis 
and formulates a collective recommended treatment pathway.     
 
Intervention is normally considered once the TAA reaches 5.5cm or is growing at a rate of more than 
0.5cm per year.  Below this threshold patients will undergo surveillance of their aortic diameter and 
will receive antihypertensive medication to reduce the risk of rupture or dissection, repeat imaging 
is completed on a 3, 6 or 12 months basis depending on current size. Patients will be optimised in 
terms of risk factor reduction which includes best medical therapy to reduce overall cardiovascular 
risk, this may include antiplatelet medication, statin treatment, optimisation of diabetic control, and 
smoking cessation.  Ultimately the size at  which treatment is recommended is individually assessed 
and can be higher in patients who have significant comorbidities or lower in certain patients, for 
example a patient with Marfan’s or Loeys-Dietz syndrome or in patients who are symptomatic, 
(Goldfinger et al., 2014).   
 
The location of the aneurysm is an important factor when making treatment decisions.  Aneurysms 
of the ascending aorta are usually treated surgically, by replacing the aneurysmal portion of the 
aorta with a Dacron graft in the operating theatre setting under general anaesthetic.  For aneurysms 
of the descending aorta exceeding 5.5cm and for thoraco-abdominal aortic aneurysms, endovascular 
therapy is now the treatment of choice, as the surgery is less invasive with a shorter recovery time, 
(Svensson et al., 2008).  These patients are usually treated in an interventional radiology suite and 
the team performing the procedure includes both a radiologist and radiographer in addition to the 
surgical, anaesthetic and scrub teams.  However, around 25% of patients are not anatomically 
suitable for endovascular repair.  A common reason for patients in this cohort to be turned down for 
endovascular repair is a lack of favourable ‘landing zones’ for the stent above and below the 
aneurysmal portion of the aorta.  Unfavourable landing zones increase the risk of endoleak (blood 
flow into the aneurysm sac), (Booher & Eagle, 2011).  Patients who present with arch aneurysms 
may be treated surgically, but for those who are deemed particularly high-risk, hybrid options exist 
that involve endovascular stent grafting of the thoracic aorta (TEVAR) (Figure 2), with extra-anatomic 
bypass (carotid-carotid or carotid-subclavian) to permit stent-graft coverage of the origin of the 
carotid artery, (Goldfinger et al., 2014).  These hybrid procedures are performed in specialist 
complex aortic centres, so the patient may need to travel further afield to receive specialist 
treatment. For patients who are treated with endovascular techniques, lifelong follow-up in the 
form of regular CT surveillance is required to check for the development of endoleaks, device 
migration, or stent-graft failure, (Sharma & Kyriakides, 2007).    
 
 
Complications 
 
Morbidity and mortality rates after thoracic aortic aneurysm repair are high, complication rates 
depends on patients ability to undergo extensive surgery, patients at higher risk of morbidity and 
mortality include the elderly, patients with significant co-morbidities especially renal disease, 
respiratory insufficiency and cardiac disease.  Patients are therefore closely monitored post-
operatively in either intensive care or high dependency settings. One of the most feared 
consequences of thoracic aortic aneurysms repair is paraplegia, due to changes in the blood supply 
to the spinal cord this can be as a result of ischaemia or reperfusion.   Paraplegia is not only 
associated with severe disability and poor quality of life, but also with decreased survival rates, 
(Svensson et el. 1991).  Paraplegia can affects up to 22% of patients undergoing thoraco-abdominal 
aortic aneurysm repair, though the risk for those undergoing isolated thoracic repair is reduced, 
(Bicknell et al., 2009).  Various techniques have been shown to reduce the risk of spinal cord 
ischaemia, including revascularisation of intercostal arteries supplying the cord and spinal cord 
cooling, (Bicknell et al., 2009).  Post-operatively, nurses working in critical care settings play a key 
role in maintaining a high mean arterial pressure (often through inotropic support) and in managing 
cerebral spinal fluid (CSF) drainage, in order to optimise cord perfusion.  Spinal cord perfusion is 
directly associated with mean arterial pressure and CSF pressure.  Cross clamping of the aorta or 
coverage of the arteries supplying the cord with an endograft results in spinal cord ischaemia, 
leading to increased CSF production and a rise in CSF pressure.  CSF drainage is therefore a key 
adjunct to prevent spinal cord compartment syndrome secondary to spinal cord oedema, (Murakami 
et al., 2004). 
 
 
 
Conclusion 
The formation of aneurysms is multifactorial and complex.  Aneurysms can involve different parts of 
the aorta and currently there are a variety of treatment options available.  The MDT plays a vital role 
in assessing each patient individually to ascertain treatment options and calculate anaesthetic risk. 
This is balanced against risk of rupture and risk of complications aiming to establish a collective 
decision of which is the most effective treatment and at what time/size this should be performed.  
Patients undergoing intervention to repair thoracic aneurysms are at risk of life changing 
complications.   Increasing practitioner knowledge and understanding of aneurysm formation, risk 
factors and surgical intervention can help to ensure patients receive optimal nursing care reducing 
overall risk of complications and mortality. 
 
Figure 1 
Types of Aortic Dissection 
 
Figure 2 - TEVAR 
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